For citations:
Khasanov N.R. Effects of SGLT2 inhibitor dapagliflozin in patients with heart failure with reduced ejection fraction. Russian Journal of Cardiology. 2020;25(8):4049. (In Russ.) https://doi.org/10.15829/1560-4071-2020-4049
Khasanov N.R. Effects of SGLT2 inhibitor dapagliflozin in patients with heart failure with reduced ejection fraction. Russian Journal of Cardiology. 2020;25(8):4049. (In Russ.) https://doi.org/10.15829/1560-4071-2020-4049